News ArchivesRead News

Your Parkinson's News Update for the Week of 10.19.20

Monday October 19, 2020
New Study May Reveal Link to Lipids
Playing a Key Role in Parkinson's
Proceedings of the National Academy of Sciences via Medical Xpress
In a novel research study conducted by a team from the Neurodegeneration Institute at McLean Hospital, investigators believe they have found key brain cell changes involving lipids, inflammation, and the development of Parkinson's.
"Our study emphasizes the importance of cooperative use, storage, and transport of lipids between brain cell types in Parkinson's disease. Mechanisms involved in balancing cellular lipids—especially neutral lipids—such as we have characterized here, have been relatively understudied in the neurodegenerative diseases," explained Oeystein R. Brekk, Ph.D., an assistant neuroscientist at the Neuroregeneration Institute and first author of the study.
The 'Global Burden of Disease' & How to Reduce Human Suffering:
3 Lessons From A Seminal Public Health Study
Before COVID-19, the health experts who specialized in infectious disease and pandemic readiness "lived in separate universes":
"[S]uddenly COVID-19 comes along and we find out that obesity and blood pressure are key determinants of what your risk of death from COVID is. And it highlights how we have older populations and more of these risk factors and we are creating far greater vulnerability. Many of the drivers of different category of illness — known as 'non-communicable diseases' — actually tend to get worse as countries start to move up the socio-economic scale.
A Patient Perspective on Early-Onset Parkinson
The American Journal of Managed Care
In this online webinar (recorded video conversation), Michael S. Fitts, assistant dean for user access and diversity for The University of Alabama at Birmingham, speaks on his experience being diagnosed with early-onset Parkinson's disease at the age of 38 and the challenges and misconceptions associated with the condition.